Suppr超能文献

一例引人关注的谵妄病例:认识与自身免疫性甲状腺炎相关的类固醇反应性脑病。

An Intriguing Case of Delirium: Recognizing Steroid-Responsive Encephalopathy Associated With Autoimmune Thyroiditis.

作者信息

Surapaneni Devipriya, Sam Noel, Dasi Sharath Chandra, N Bhubaneshwar

机构信息

Internal Medicine, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Chennai, IND.

Internal Medicine, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences, chennai, IND.

出版信息

Cureus. 2024 Sep 29;16(9):e70447. doi: 10.7759/cureus.70447. eCollection 2024 Sep.

Abstract

Steroid-responsive encephalopathy, also known as Hashimoto's encephalopathy, is an uncommon autoimmune neuroendocrine disorder linked to thyroiditis. It presents a variable range of clinical symptoms, making it challenging to diagnose. SREAT (steroid-responsive encephalopathy associated with autoimmune thyroiditis) is considered a diagnosis of exclusion. Diagnosing SREAT poses a challenge as its symptoms can overlap with those of acute conditions such as encephalitis and meningitis, as well as various autoimmune disorders and issues related to substance toxicity and abuse, all of which must be ruled out prior to establishing a definitive diagnosis and starting treatment. However, high anti-TPO antibodies (anti-thyroid peroxidase) in serum and rarely in the CSF favor the diagnosis of the condition. Although rare, Hashimoto's encephalopathy should be considered when managing cases of unexplained encephalopathy. Treatment of choice in these sets of patients includes high-dose corticosteroid therapy. We present a case of Hashimoto's encephalopathy in a middle-aged woman who arrived at our emergency department with altered mental status and facio-brachial seizures. After excluding various potential causes of acute encephalopathy, a diagnosis of SREAT was made. Testing of serum and cerebrospinal fluid (CSF) indicated the presence of anti-thyroid peroxidase (anti-TPO) antibodies, which is uncommon in CSF. Following intravenous steroid therapy, the patient experienced substantial improvement, reinforcing the diagnosis.

摘要

类固醇反应性脑病,也称为桥本脑病,是一种与甲状腺炎相关的罕见自身免疫性神经内分泌疾病。它呈现出一系列不同的临床症状,这使得诊断具有挑战性。与自身免疫性甲状腺炎相关的类固醇反应性脑病(SREAT)被认为是一种排除性诊断。诊断SREAT具有挑战性,因为其症状可能与脑炎和脑膜炎等急性疾病以及各种自身免疫性疾病以及与物质毒性和滥用相关的问题重叠,在确立明确诊断并开始治疗之前,所有这些都必须排除。然而,血清中高抗甲状腺过氧化物酶(anti-TPO)抗体,脑脊液中则很少见,这有利于该疾病的诊断。尽管罕见,但在处理不明原因的脑病病例时应考虑桥本脑病。这些患者的首选治疗方法包括大剂量皮质类固醇治疗。我们报告一例中年女性桥本脑病病例,该患者因精神状态改变和面臂部癫痫发作前来我院急诊科就诊。在排除急性脑病的各种潜在原因后,做出了SREAT的诊断。血清和脑脊液(CSF)检测显示存在抗甲状腺过氧化物酶(anti-TPO)抗体,这在脑脊液中并不常见。静脉注射类固醇治疗后,患者病情有显著改善,进一步证实了诊断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2e40/11521318/3d32db7f24c8/cureus-0016-00000070447-i01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验